Información del artículo
Resumen
Las enfermedades osteocondensantes son un grupo de patologías poco frecuentes que se caracterizan por aumento de la masa ósea, comprometiendo tanto a huesos largos como a huesos planos. Tradicionalmente, la radiología simple ha permitido su diagnóstico al identificar patrones de afectación ósea característicos de cada enfermedad. Actualmente, la caracterización molecular y genética ha facilitado la comprensión del sustrato fisiopatológico y la expresión fenotípica de estás patologías, sin embargo, la radiología simple continua teniendo un valor inconmesurable en el reconocimiento de las enfermedades osteocondensantes.
Palabras clave:
osteoesclerosis
hiperostosis
enfermedades esclerosantes del hueso
huesos largos
Summary
Sclerosing bone disorders are a rare group of diseases characterized by increased bone mass in both long and flat bones. Traditionally, plain radiography has allowed the diagnosis of these diseases identifying characteristic patterns of bone involvement. At present, the molecular and genetic characterization of these diseases has provided a better understand of their pathophysiology and phenotypic expression, however plain radiography continues to have an important role in the recognition of sclerosing bone disorders.
Key words:
osteosclerosis
hyperostosis
sclerosing bone disorders
long bones
El Texto completo está disponible en PDF
Referencias
[1.]
M.C. de Vernejoul, U. Kornak.
Heritable sclerosing bone disorders: presentation and new molecular mechanisms.
Ann N Y Acad Sci, 1192 (2010), pp. 269-277
[2.]
J. Mejía-Vallejo, E. Calvo, J.F. Restrepo, A. Iglesias-Gamarra.
Enfermedades osteocondensantes: una nueva visión clínico-radiológica soportada en la genética y la inmunoosteología.
Revista Colombiana de Reumatología, 16 (2009), pp. 46-60
[3.]
C.E. Toro, M.A. Quintana, J.F. Restrepo, G. Quintana, F. Rondón, Sánchez Álvaro, F. Molina, A. Iglesias- Gamarra.
Osteoesclerosis axiales Propuesta para una nueva aproximación diagnóstica.
Revista Colombiana de Reumatología, 14 (2007), pp. 44-52
[4.]
O.D. Bénichou, J.D. Laredo, M.C. de Vernejoul.
Type II autosomal dominant osteopetrosis (Albers-Schönberg disease): clinical and radiological manifestations in 42 patients.
Bone, 26 (2000), pp. 87-93
[5.]
J. Bollerslev.
Autosomal dominant osteopetrosis: bone metabolism and epidemiological, clinical, and hormonal aspects.
Endocr Rev, 10 (1989), pp. 45-67
[6.]
E. Granados Sandoval, J. Martínez, R. Zepeda, A. Trejo, C. Sandoval, J.C. Barrón.
Osteopetrosis (enfermedad de Albers-Schonberg): reporte de un caso y revisión clínica.
Med Int Mex, 23 (2007), pp. 542-545
[7.]
S. Benavente, A. Castillo, Y. Sánchez, Osteopetrosis:.
reporte de un caso en paciente de 20 años.
Rev. Chil. Reumatol, 27 (2011), pp. 25-28
[8.]
J. Bollerslev, P.E. Andersen Jr..
Radiological, biochemical and hereditary evidence of two types of autosomal dominant osteopetrosis.
Bone, 91 (1998), pp. 7-13
[9.]
G. Quintana, A. Fernández, J.F. Restrepo, A. Rojas, E. Calvo, F. Rondón, A. Sánchez, E. Forero, G.A. Iglesias.
Osteomesopicnosis asociada a litiasis renal Informe de un caso. Diagnóstico diferencial de las enfermedades osteoesclerosantes axiales.
Revista Colombiana de Reumatología, 11 (2004), pp. 341-346
[10.]
J. Bollerslev.
Osteopetrosis. A genetic and epidemiological study.
Clin Genet, 31 (1987), pp. 86-90
[11.]
S.G. Waguespack, S.L. Hui, L.A. Dimeglio, M.J. Econs.
Autosomal dominant osteopetrosis: clinical severity and natural history of 94 subjects with a chloride channel 7 gene mutation.
J Clin Endocrinol Metab, 92 (2007), pp. 771-778
[12.]
S.C. Kaste, K.A. Kasow, E.M. Horwitz.
Quantitative bone mineral density assessment in malignant infantile osteopetrosis.
Pediatr Blood Cancer, 48 (2007), pp. 181-185
[13.]
A. Iglesias, C. Hernández-Cassis, J. Cueto, A. Chichilla, O. Velasco, J. Mercado, et al.
Hiperostosis cortical generalizada Presentación de cuatro casos. Descripción de una nueva variante.
Salud Uninorte, 4-5 (1988), pp. 181-196
[14.]
C. Hernández-Cassis, C.K. Vogel, T.P. Hernandez, M.J. Econs, M. Iglesias, A. Iglesias, et al.
Autosomal dominant hyperostosis/osteosclerosis with high serum alkaline phosphatase activity.
J Clin Endocrinol Metab, 88 (2003), pp. 2650-2655
[15.]
M.C. de Vernejoul.
Sclerosing bone disorders.
Best Pract Res Clin Rheumatol, 22 (2008), pp. 71-83
[16.]
International Working Group on Constitutional Disease of Bone..
International Nomenclature and Classification of the Osteochondrodysplasias. 1997.
Am J Med Genet, 79 (1998), pp. 376-382
[17.]
M.P. Whyte, A. Chines, D.P. Silva Jr., Y. Landt, J.H. Ladenson.
Creatine kinase brain isoenzyme (BB-CK) presence in serum distinguishes osteopetroses among the sclerosing bone disorders.
J Bone Miner Res, 11 (1996), pp. 1438-1443
[18.]
A. Frattini, P.J. Orchard, C. Sobacchi, S. Giliani, M. Abinun, J.P. Mattsson, et al.
Defects in TCIRG1 subunit of the vacuolar proton pump are responsible for a subset of human autosomal recessive osteopetrosis.
Nature Genetics, 25 (2000), pp. 343-346
[19.]
A. Frattini, A. Pangrazio, L. Susani, C. Sobacchi, M. Mirolo, M. Abinun, et al.
Chloride channel ClCN7mutations are responsible for severe recessive, dominant, and intermediate osteopetrosis.
The Journal of Bone and Mineral Research, 18 (2003), pp. 1740-1747
[20.]
E. Van Hul, D. Mathysen, J. Bollerslev, J. Gram, W. Van Hul.
Autosomal dominant osteopetrosis type I is genetically linked to the same region on human chromosome 11 as the high bone mass phenotype.
J Bone Miner Res, 15 (2000), pp. S260
[21.]
W. Van Hul, J. Bollerslev, J. Gram, E. Van Hul, W. Wuyts, O. Benichou, et al.
Localization of a gene for autosomal dominant osteopetrosis Albers-Schonberg disease to chromosome 1p21.
Am J Hum Genet, 61 (1997), pp. 363-369
[22.]
B.D. Gelb, G.P. Shi, H.A. Chapman, R.J. Desnick.
Pycnodysostosis, a lysosomal disease caused by cathepsin K deficiency.
Science, 273 (1996), pp. 1236-1238
[24.]
H.G. Jacobson.
Dense bone—too much bone: Radiological considerations and differential diagnosis (parts I and II).
Skeletal Radiol, 13 (1985), pp. 97-113
[25.]
J.G. Edelson, S. Obad, R. Geiger, et al.
Pycnodysostosis: Orthopedic aspects, with a description of 14 new cases.
Clin Orthop, 280 (1992), pp. 263-276
[26.]
K. Janssens, P. ten Dijke, S.H. Ralston, C. Bergmann, W. Van Hul.
Transforming growth factor-beta 1 mutations in Camurati-Engelmann disease lead to increased signaling by altering either activation or secretion of the mutant protein.
J Biol Chem, 278 (2003), pp. 7718-7724
[27.]
K. Janssens, F. Vanhoenacker, M. Bonduelle, L. Verbruggen, L. Van Maldergem, S. Ralston, et al.
Camurati-Engelmann disease: review of the clinical, radiological, and molecular data of 24 families and implications for diagnosis and treatment, Journal of Medical Genetics.
, 43 (2006), pp. 1-11
[28.]
F.M. Vanhoenacker, L.H. De Beuckeleer, W. Van Hul, W. Balemans, G.J. Tan, S.C. Hill, A.M. De Schepper.
Sclerosing bone dysplasias: genetic and radioclinical features.
Eur Radiol, 10 (2000), pp. 1423-1433
[29.]
J. Hellemans, O. Preobrazhenska, A. Willaert, P. Debeer, P.C. Verdonk, T. Costa, et al.
Loss-of-function mutations in LEMD3 result in osteopoikilosis Buschke- Ollendorff syndrome and melorheostosis.
Nat. Genet, 36 (2004), pp. 1213-1218
[30.]
V. Krishnan, H.U. Bryant, O.A. Macdougald.
Regulation of bone mass by Wnt signaling.
The Journal of Clinical Investigation., 116 (2006), pp. 1202-1209
[31.]
W. Balemans, N. Patel, M. Ebeling, E. Van Hul, W. Wuyts, C. Lacza, et al.
Identification of a 52 kb deletion downstream of the SOST gene in patients with van Buchem disease.
J Med Genet, 39 (2002), pp. 91-97
[32.]
M.E. Brunkow, J.C. Gardner, J. Van Ness, B.W. Paeper, B.R. Kovacevich, S. Proll, et al.
Bone dysplasia sclerosteosis results from loss of the SOST gene product, a novel cystine knot-containing protein.
Am J Hum Genet, 68 (2001), pp. 577-589
[33.]
V. Krishnan, H.U. Bryant, O.A. Macdougald.
Regulation of bone mass by Wnt signaling.
J Clin Invest, 116 (2006), pp. 1202-1209
[34.]
H. Hamersma, J. Gardner, P. Beighton.
The natural history of sclerosteosis.
Clin Genet, 63 (2003), pp. 192-197
[35.]
L.M. Boyden, J. Mao, J. Belsky, L. Mitzner, A. Farhi, M.A. Mitnick, et al.
High bone density due to a mutation in LDL-receptor-related protein 5.
The New England Journal of Medicine, 346 (2002), pp. 1513-1521
[36.]
R.D. Little, J.P. Carulli, R.G. Del Mastro, J. Dupuis, M. Osborne, C. Folz, et al.
A mutation in the LDL receptorrelated protein 5 gene results in the autosomal dominant high-bone-mass trait.
American Journal of Human Genetics, 70 (2002), pp. 11-19
Los autores declaran no presentar ningún conflicto de interés al momento de la redacción del manuscrito.
Copyright © 2011. Asociación Colombiana de Reumatología
